N/A
N=20
Virtual Reality Pain Neuroscience Education for Middle School Students
Pain · Education · Virtual Reality
Bottom Line
View on ClinicalTrials.gov: NCT04470375 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Change From Baseline in Pain Beliefs Questionnaire Score After VR Intervention Approximately 45 Minutes Later — .35; .95; .45; .55 score on a scale — p=.137
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Virtual Reality Pain Neuroscience Education (Behavioral)
- Age
- Pediatric · 10+ yrs
- Sex
- All
- Sponsor
- University of South Dakota
- Primary completion
- Aug 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Pain Beliefs Questionnaire Score After VR Intervention Approximately 45 Minutes Later |
.35; .95; .45; .55; -.1 | .137 |
| PRIMARY Change in Baseline Revised Neurophysiology of Pain Questionnaire to Post Intervention of VR, Approximately 45 Minutes Later |
1.45 | .010 sig |
| PRIMARY Change in Baseline Physical Activity Subscale of the Fear Avoidance Belief Questionnaire Scores to Post VR Viewing, Approximately 45 Minutes Later |
.2; -.05; .55; -1.0; -.35 | .591 |
Summary
Investigating the use of a Virtual Reality (VR) pain neuroscience education (PNE) platform with middle school students. The investigators have previously studied the use of PNE with in person educational sessions with middle school kids and video recorded sessions. This study will be looking into utilizing the VR platform for delivery of the educational information.
Eligibility Criteria
Inclusion Criteria
- willing to view VR educational session
- in grades 5, 6, 7, or 8.
Exclusion Criteria
- has been through PNE educational program previously
- aversion to VR or problems with viewing VR in the past
- history of epilepsy or seizures
- eye surgery or injury within the last 6 months
- open sores or wounds around where VR googles are worn on face
- anyone who has had a concussion that has not been cleared for full activity or experiencing any post-concussion syndrome symptoms currently.
Data sourced from ClinicalTrials.gov (NCT04470375). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.